Feasibility of Paclitaxel in a Patient with Anthracycline-induced Congestive Heart Failure

Author： Colleoni M.   Nelli P.   Vicario G.   Sgarbossa G.   Pancheri F.   Manente P.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.33, Iss.2, 1997-02, pp. : 321-322

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anthracycline-induced chronic cardiotoxicity and heart failure

By Appel Jon M.   Nielsen Dorte   Zerahn Bo   Jensen Benny V.   Skagen Knud  

Acta Oncologica, Vol. 46, Iss. 5, 2007-01 ,pp. : 576-580

Informa Healthcare

Access to resources Recommend Favorite

Congestive Heart Failure—A Cardiovascular Orphan No More

By  

The Genesis Report - Rx, Vol. 8, Iss. 5, 1999-08 ,pp. : 31-37

Adis International

Access to resources Recommend Favorite

Feasibility of Dose-intensified Paclitaxel after Chemotherapy-induced Renal Insufficiency in a Patient with Renal Transplantation

By Luftner D.   Flath B.   Akrivakis C.   Prinz B.   Mergenthaler H.G.   Wernecke K.D.   Possinger K.  

European Journal of Cancer, Vol. 35, Iss. 2, 1999-02 ,pp. : 325-325

Elsevier

Access to resources Recommend Favorite

Radiation- and anthracycline-induced cardiac toxicity and the influence of ErbB2 blocking agents

By Seemann Ingar   Poele Johannes   Song Ji-Ying   Hoving Saske   Russell Nicola   Stewart Fiona  

Breast Cancer Research and Treatment, Vol. 141, Iss. 3, 2013-10 ,pp. : 385-395

Springer Publishing Company

Access to resources Recommend Favorite

Red cell distribution width predicts short- and long-term outcomes of acute congestive heart failure more effectively than hemoglobin

By          

Experimental and Therapeutic Medicine, Vol. 8, Iss. 2, 2014-01 ,pp. : 600-606

Spandidos Publications

Access to resources Recommend Favorite